Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05378711 · ClinicalTrials.gov registry record · Phase 2
Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine
A Phase 2 study, sponsored by Michigan State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT05378711 is a Phase 2 study that has completed, run by Michigan State University. The registered enrollment target is 6 participants.
The verdict
NCT05378711, a Phase 2 study, has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
The Department of Counseling, Educational Psychology, and Special Education and the Department of Psychiatry at Michigan State University have coordinated efforts to provide a diagnostic and treatment investigation for children, ages seven to eighteen, with Selective Mutism. The purpose of this study is to examine the utility of fluoxetine for the treatment of this debilitating disorder. Fluoxetine is expected to improve social anxiety and selective mutism symptomology.
Interventions
- DRUG Fluoxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2014-01-01 |
| Est. Completion | 2015-05-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05378711
The ClinicalTrials.gov registry entry for NCT05378711 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluoxetine is the first listed.
NCT05378711 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05378711 about?
NCT05378711 is a clinical study titled "Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine". The Department of Counseling, Educational Psychology, and Special Education and the Department of Psychiatry at Michigan State University have coordinated efforts to provide a diagnostic and treatment investigation for children, ages seven to eighteen, with Selective Mutism. The purpose of this stud...
What is the current status of trial NCT05378711?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2014-01-01. Estimated completion is 2015-05-30.
What interventions are being tested in trial NCT05378711?
The interventions under investigation include: Fluoxetine (DRUG).
Who is sponsoring clinical trial NCT05378711?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.